“It was pretty much hell for a year”: A Labcorp employee’s journey with dermatomyositis

When a rash first appeared on Donna Carter's forehead in the summer of 2021, she thought little of it. Assuming it was just a reaction to a new skin cream, Carter consulted a telehealth doctor who prescribed some topical treatments. But as weeks passed, the rash persisted. 

Planning for price transparency regulations: How health system labs play a role

Bryan Vaughn, senior vice president of health systems at Labcorp, shares his perspective on price transparency regulations and the impact health systems labs play in these changes.

Discovery Oncology: Patient-derived xenograft models

Improve your therapeutic efficacy predictions with Labcorp's PDX models

Leveraging lab data to combat diabetes and chronic kidney disease

Social determinants of health impact an estimated 80%-90% of patient outcomes. Learn how you can leverage lab data to enhance population health, see hot spots that need attention and target them through preventive and gaps in care programs

Nonclinical Solutions - Toxicology

Propel your development program with Labcorp's comprehensive toxicology solutions. Toxicology plays a critical role in assessing and mitigating potential adverse effects, ensuring regulatory compliance, and understanding toxicity mechanisms to optimize drug safety and efficacy. To enhance the therapeutic potential of your drug candidate while minimizing patient risk, partnering with a laboratory that offers extensive capabilities and expertise is essential.

Three best practices to cultivate healthier, thriving communities

Managed care organizations are no strangers to alarming statistics about barriers to healthcare access. Nevertheless, the numbers are still astounding when laid out next to each other—especially for those residing in the rural United States. We can help cultivate healthier, thriving communities with the best practices below.

Gilles Baud, PhD

Dr. Gilles Baud joined Labcorp Biopharma Laboratory Services in 2023, working on the validation of performances of molecular biology assays, ranging from qPCRs to NGS, for the department of genomics.

Gilles received his PhD from the University of Lausanne, where he worked at the interface among molecular biology, bioinformatics and microbiology.